Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Efficacy of Qualia Testosterone+ on Testosterone Levels in Adult Males

Qualia Life Sciences · NCT07556458

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 28–65 · Men only
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
75
US sites recruiting
1
Study start
May 19, 2026
Record last updated
October 5, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a double-blind, placebo-controlled, triple-arm, parallel-group study evaluating the efficacy and tolerability of two distinct Qualia Testosterone+ formulations, novel dietary supplements formulated to support endogenous testosterone, in adult males aged 28-65. Approximately 75 participants will be assigned equally to receive Qualia Testosterone+ Formula 1, Qualia Testosterone+ Formula 2, or a matched placebo (3 capsules once each morning) for 28 days. The primary outcome is between-group change in total testosterone from baseline to day 28. Secondary outcomes include changes in free (dialysis) testosterone, the Aging Male Symptoms Scale, the PROMIS Short Form v1.0 - Fatigue 10a, and safety and tolerability assessments. Blood samples will be collected in a clinical laboratory setting, while symptom and safety assessments will be completed electronically at home.

Being studied: Qualia Testosterone+; Placebo

Conditions: Low Testosterone Levels

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Provide voluntary, written, informed consent to participate in the study
  • Agree to provide a valid cell phone number and are willing to receive communications through text
  • Can read and write English
  • Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly
  • Willing to complete questionnaires, records, and diaries associated with the study.
  • Male participants aged 28-65
  • A ≤500 ng/dL Total Testosterone at baseline
  • Willing and able to visit a local blood draw facility for required blood sample collections
  • Live within 20 miles of a suitable blood draw facility
  • Willing to not consume any supplements containing Testosterone or botanicals known to impact hormones starting about 2 weeks prior to the baseline blood test and continuing through the intervention period.

Exclusion Criteria

  • Known food intolerances/allergy to any ingredients in the product
  • Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
  • Having had a significant cardiovascular event in the past 6 months
  • Taking MAO inhibitors, SSRIs, blood thinners, or any other psychiatric or neurological medicines
  • On immunosuppressive therapy
  • Individuals who were deemed incompatible with the test protocol
  • Adults lacking capacity to consent
  • Female
  • Have Hypogonadism
  • On Testosterone Replacement Therapy
  • Taking Gonadotropin-releasing hormone (GnRH) injections or gonadotropins (hCG or FSH)

Recruiting US locations

Study contacts (from the official record)

  • Colin Gardner, PhD · 678-387-7924 · colin@qualialife.com
All nutrition & metabolism studies in California →
Efficacy of Qualia Testosterone+ on Testosterone Levels in Adult Males (NCT07556458) | Bored Studies